Major plasma products marketed by CSL Behring
Haemophilia and Other Coagulation Disorders
Coagulation therapies are used to treat bleeding disorders such as haemophilia and Von Willebrand disease.
- Recombinant Factor VIII
- Helixate® FS
- Helixate® NexGen
- Plasma-derived Factor VIII
- Beriate® P
- Haemate® P
- Humate-P®
- Monoclate-P®
- Plasma-derived Factor IX
- Berinin® P
- Mononine®
- Factor IX P Behring
- Von Willebrand Disease
- Haemate® P
- Humate-P®
- Stimate®
- Other Coagulation Disorders
- Beriplex® P/N
- Fibrogammin® P
- Haemocomplettan® P
- Kybernin® P
Critical Care Conditions
Critical care products are used to treat shock, sepsis and severe burns, and are used in cardiac surgery.
- Trauma Therapies
- AlbuRx™ 5 and 25
- AlbuRx™ 5 and 20
- Albuminar® -5 and -25
- Albumin ZLB 5% and 20%
- Beriplex® P/N
- Haemocomplettan® P
- Human-Albumin 20% Behring, low salt
- Inhibitors
- Berinert® P
- Kybernin® P
- Cardiology
- Streptase®
Wound Healing
Wound healing therapies are used to facilitate healing.
- Beriplast® P
- Fibrogammin® P
- Tachocomb®
Alpha 1-Proteinase Inhibitor Deficiency
For people at risk from life-shortening emphysema through a genetic deficiency in their synthesis of this protein.
- Zemaira®
Immune Disorders and Immune Therapy
Immunoglobulins are used to treat infections and autoimmune diseases, and to prevent haemolytic disease in the newborn.
- Polyvalent Immunoglobulins
- Beriglobin® P
- Carimune® NF
- Redimune®
- Redimune® NF Liquid
- Sandoglobulin®
- Sandoglobulin® NF Liquid
- Gamma-Venin® P
- Gammar® -P.I.V.
- Venimmun® N
- Vivaglobin®
- Immune Globulin Subcutaneous (Human)
- Specific Immunoglobulins
- Berirab® P
- Hepatitis B Immunoglobulin P
Behring
- Rhesogamma® P
- Rhophylac®
- Tetagam® P
- Varicellon® P
Back | Next |
